134 related articles for article (PubMed ID: 25471697)
1. Differential impact of the neutrophil-lymphocyte ratio on the survival of patients with stage IV gastric cancer.
Tanaka H; Muguruma K; Toyokawa T; Kubo N; Ohira M; Hirakawa K
Dig Surg; 2014; 31(4-5):327-33. PubMed ID: 25471697
[TBL] [Abstract][Full Text] [Related]
2. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.
Yu L; Lv CY; Yuan AH; Chen W; Wu AW
World J Gastroenterol; 2015 May; 21(20):6280-6. PubMed ID: 26034363
[TBL] [Abstract][Full Text] [Related]
3. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.
Graziosi L; Marino E; De Angelis V; Rebonato A; Cavazzoni E; Donini A
Am J Surg; 2015 Feb; 209(2):333-7. PubMed ID: 25190544
[TBL] [Abstract][Full Text] [Related]
5. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
Miyamoto R; Inagawa S; Sano N; Tadano S; Adachi S; Yamamoto M
Eur J Surg Oncol; 2018 May; 44(5):607-612. PubMed ID: 29478743
[TBL] [Abstract][Full Text] [Related]
6. The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?
Kim EY; Lee JW; Yoo HM; Park CH; Song KY
Ann Surg Oncol; 2015 Dec; 22(13):4363-70. PubMed ID: 25805235
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and surgical treatment of gastric cancer invading adjacent organs.
Zhang M; Zhang H; Ma Y; Zhu G; Xue Y
ANZ J Surg; 2010; 80(7-8):510-4. PubMed ID: 20795964
[TBL] [Abstract][Full Text] [Related]
8. [Neutrophil-lymphocyte ratio as a prognostic factor in gastric cancer].
Ma JP; Wang Z; Lin JW; Wu KM; Chen JH; Chen CQ; Cai SR; He YL; Zhan WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Dec; 14(12):944-7. PubMed ID: 22205454
[TBL] [Abstract][Full Text] [Related]
9. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
Qiu JL; Deng MG; Li W; Zou RH; Li BK; Zheng Y; Lao XM; Zhou K; Yuan YF
Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
[TBL] [Abstract][Full Text] [Related]
10. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
11. Impact of Preoperative Neutrophil to Lymphocyte Ratio and Postoperative Infectious Complications on Survival After Curative Gastrectomy for Gastric Cancer: A Single Institutional Cohort Study.
Mohri Y; Tanaka K; Toiyama Y; Ohi M; Yasuda H; Inoue Y; Kusunoki M
Medicine (Baltimore); 2016 Mar; 95(11):e3125. PubMed ID: 26986164
[TBL] [Abstract][Full Text] [Related]
12. A reliable risk score for stage IV esophagogastric cancer.
Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
[TBL] [Abstract][Full Text] [Related]
13. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancer.
Szor DJ; Roncon Dias A; Pereira MA; Ramos MFKP; Zilberstein B; Cecconello I; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):851-857. PubMed ID: 29509963
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.
Wang SC; Chou JF; Strong VE; Brennan MF; Capanu M; Coit DG
Ann Surg; 2016 Feb; 263(2):292-7. PubMed ID: 25915915
[TBL] [Abstract][Full Text] [Related]
16. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
[TBL] [Abstract][Full Text] [Related]
17. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.
Murakami Y; Saito H; Shimizu S; Kono Y; Shishido Y; Miyatani K; Matsunaga T; Fukumoto Y; Fujiwara Y
Anticancer Res; 2019 May; 39(5):2583-2589. PubMed ID: 31092456
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of preoperative neutrophil-to-lymphocyte ratio in the elderly patients over 75 years old with gastric cancer].
Zhang X; Li S; Guo Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):526-9. PubMed ID: 27215519
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of the Neutrophil/Lymphocyte Ratio in Peritoneal and/or Metastatic Disease at Staging Laparoscopy for Gastric and Esophageal Adenocarcinoma.
Grenader T; Plotkin Y; Mohammadi B; Dawas K; Hashemi M; Mughal M; Bridgewater JA
J Gastrointest Cancer; 2015 Sep; 46(3):267-71. PubMed ID: 25952408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
